Titlebook: Liquid Biopsies; Methods and Protocol Tao Huang,Jialiang Yang,Geng Tian Book 2023 The Editor(s) (if applicable) and The Author(s), under ex

cobble

书目名称Liquid Biopsies影响因子(影响力)




书目名称Liquid Biopsies影响因子(影响力)学科排名




书目名称Liquid Biopsies网络公开度




书目名称Liquid Biopsies网络公开度学科排名




书目名称Liquid Biopsies被引频次




书目名称Liquid Biopsies被引频次学科排名




书目名称Liquid Biopsies年度引用




书目名称Liquid Biopsies年度引用学科排名




书目名称Liquid Biopsies读者反馈




书目名称Liquid Biopsies读者反馈学科排名

树胶

Cell-Free RNA Sequencing from Biofluid Samples,is relatively unstable but could contain potential biomarkers, and some studies have demonstrated that cfRNA sequencing may be developed to be a promising diagnostic assay for disease detection. In this chapter, we introduce a modified protocol for the detection of cfRNA based on next-generation seq

Impugn

Detection of Circulating Tumor DNA in Plasma Using Targeted Sequencing,nd contains variations, including mutation, deletion, insertion, rearrangement, copy number variation, and methylation. Therefore, biomarkers identified in ctDNA show promising clinical applications in early diagnosis, recurrence monitoring, and conducting individualized treatment. In this chapter,

Morsel

允许

Detection of Microorganisms in Body Fluid Samples,encing is simple, fast, and cost-effective. It overcomes the problem that some microorganisms cannot be isolated or cultured. Low abundant bacteria can also be amplified and sequenced, but the resolution of classification can hardly reach species or sub-species level; moreover, this methodology is m

ATOPY

obligation

Exposition

Diagnosis, Monitoring, and Prognosis of Liquid Biopsy in Cancer Immunotherapy,eresting tool that can advise in disease monitoring, treatment selection, early diagnosis, evaluation of the response, and prognosis. Cancer immunotherapy is a breakthrough in cancer treatment, which is now recognized as the “fourth pillar” of cancer treatment, after surgery, chemotherapy, and radio

FICE

The Implication of Liquid Biopsy in the Non-small Cell Lung Cancer: Potential and Expectation,were diagnosed with locally advanced or metastatic disease and have poor prognosis. Immunotherapy and targeted drugs have greatly improved the survival and prognosis of patients with advanced lung cancer. However, how to identify the optimal patients to accept those therapies and how to monitor ther

确定的事